Bryan White, PharmD, BCPS, BCIDP

University of Oklahoma Medical Center

Disclosure(s): Melinta: Advisor/Consultant; Shionogi: Grant/Research Support

Poster(s):

• (P-655) Validation Of DRIP Score And Derivation of Local Score Predicting Multi-Drug Resistant Pathogens in Patients with Community Acquired Pneumonia
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1102) Real-World Effectiveness of Dalbavancin for Invasive Gram-Positive Bacterial Infections
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1557) Using cefazolin and ceftriaxone via automated susceptibility predicts susceptibility to oral cefpodoxime but not cefuroxime in Enterobacterales
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT